Naxos study: risk of bleeding with oral anticoagulants in non-valvular atrial fibrillation patients in France

被引：0
|
作者：
Danchin, N. [1 ]
Steg, P. G. [2 ]
Hanon, O. [3 ]
Mahe, I [4 ]
Falissard, B. [5 ]
Belhassen, M. [6 ]
Dalon, F. [6 ]
Gollety, S. [7 ]
Cotte, F. E. [7 ]
Van-Ganse, E. [6 ]
机构：
[1] Univ Paris 05, Hop Europeen Georges Pompidou, Paris, France
[2] Hosp Bichat Claude Bernard, Paris, France
[3] Hosp Broca Paris, Paris, France
[4] Hosp Louis Mourier, Colombes, France
[5] INSERM, U669, Paris, France
[6] PELyon, Lyon, France
[7] Bristol Myers Squibb, Ruell Malmaison, France
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：643 / 643
页数：1
相关论文
共 50 条
  • [1] Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants
    Beshir, S. A.
    Aziz, Z.
    Yap, L. B.
    Chee, K. H.
    Lo, Y. L.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (02) : 209 - 219
  • [2] Major Bleeding Risk in Patients With Non-valvular Atrial Fibrillation Concurrently Taking Direct Oral Anticoagulants and Antidepressants
    Chang, Kuo-Hsuan
    Chen, Chiung-Mei
    Wang, Chun-Li
    Tu, Hui-Tzu
    Huang, Yu-Tung
    Wu, Hsiu-Chuan
    Chang, Chien-Hung
    Chang, Shang-Hung
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [3] Impact of Renal Function on Bleeding Risk in Patients With Non-Valvular Atrial Fibrillation Treated With Direct Oral Anticoagulants
    Kobayashi, Tomoaki
    Sotomi, Yohei
    Hirata, Akio
    Hirayama, Atsushi
    Higuchi, Yoshiharu
    [J]. CIRCULATION, 2019, 140
  • [4] Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation
    Cunha, Pedro Silva
    Monteiro, Andre Viveiros
    Cruz, Madalena Coutinho
    Malveiro, Paula
    Reis, Joao Pedro
    Portugal, Guilherme
    Dias, Ana
    Ferreira, Rui Cruz
    Oliveira, Mario Martins
    [J]. GERIATRICS, 2022, 7 (01)
  • [5] Novel oral anticoagulants in non-valvular atrial fibrillation
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 115 - 129
  • [6] New oral anticoagulants in non-valvular atrial fibrillation
    Francia P.
    Adduci C.
    Santini D.
    Musumeci B.
    Tocci G.
    [J]. High Blood Pressure & Cardiovascular Prevention, 2013, 20 (2) : 53 - 60
  • [7] Association between oral anticoagulants and risk of dementia in patients with non-valvular atrial fibrillation
    Rahman, Alvi
    Michaud, Jonathan
    Dell'Aniello, Sophie
    Moodie, Erica
    Brophy, James M.
    Durand, Madeleine
    Guertin, Jason
    Boivin, Jean-Francois
    Renoux, Christel
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 631 - 631
  • [8] Oral anticoagulants in diabetic and nondiabetic patients with non-valvular atrial fibrillation
    Derosa, G.
    Raddino, R.
    Gavazzoni, M.
    Pasini, G.
    Gaudio, G.
    Maggi, A.
    D'Angelo, A.
    Ragonesi, P. D.
    Brunetti, N.
    De Gennaro, L.
    Cattaneo, M.
    Maffioli, P.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 1409 - 1409
  • [9] Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation
    Jolobe, Oscar M. P.
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2017, 78 (07) : 416 - 416
  • [10] New anticoagulants in patients with non-valvular atrial fibrillation
    Zellerhoff, S.
    Lewalter, T.
    Eckardt, L.
    Treszl, A.
    Wegscheider, K.
    Breithardt, G.
    [J]. NERVENHEILKUNDE, 2012, 31 (11) : 813 - 820
12345